Bishop Score, Cervical Length and Multiple Proteins in Cervicovaginal Fluid at 40 Weeks to Predict Onset of Labor
1 other identifier
observational
220
1 country
1
Brief Summary
The purpose of this study is to compare Bishop score, sonographic cervical length and multiple proteins in cervicovaginal fluid at 40 weeks gestation to predict time to spontaneous labor and mode of delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 17, 2011
CompletedFirst Posted
Study publicly available on registry
July 26, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2012
CompletedDecember 10, 2013
December 1, 2013
3.8 years
March 17, 2011
December 8, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Onset of labor/delivery ≤10days
Baseline
Secondary Outcomes (1)
Cesarean delivery in labor
Baseline
Study Arms (1)
Women attending antenatal clinic
Women attending antenatal clinic were consecutively enrolled at between 39+6 and 40+1 weeks of gestation.
Interventions
Cervical length by transvaginal ultrasound Bishop score by digital examination Take cervicovaginal samples
Eligibility Criteria
Single tertiary hospital
You may qualify if:
- Women between 39+6 and 40+1 weeks of gestation
- singleton pregnancy
- viable fetus with vertex presentation
- intact amniotic membranes
- no pregnancy complications
- absence of labor
- no history of previous uterine surgery
- planned vaginal delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 463-707, South Korea
Biospecimen
cervicovaginal fluid
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kyo Hoon Park, MD, PhD
Seoul National University Bundang Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2011
First Posted
July 26, 2011
Study Start
November 1, 2008
Primary Completion
September 1, 2012
Study Completion
September 1, 2012
Last Updated
December 10, 2013
Record last verified: 2013-12